journal article·2024-05Open access

Mitochondria‐Modulating Liposomes Reverse Radio‐Resistance for Colorectal Cancer

Junmei Li, Yuhong Wang, Wenhao Shen, Ziyu Zhang, Zhiyue Su, Xia Guo, Pei Pei, Lin Hu, Teng Liu, Kai Yang, Lingchuan Guo

Advanced Science· Volume 11· Issue 18

Abstract

Abstract Complete remission of colorectal cancer (CRC) is still unachievable in the majority of patients by common fractionated radiotherapy, leaving risks of tumor metastasis and recurrence. Herein, clinical CRC samples demonstrated a difference in the phosphorylation of translation initiation factor eIF2α (p‐eIF2α) and the activating transcription factor 4 (ATF4), whose increased expression by initial X‐ray irradiation led to the resistance to subsequent radiotherapy. The underlying mechanism is studied in radio‐resistant CT26 cells, revealing that the incomplete mitochondrial outer membrane permeabilization (iMOMP) triggered by X‐ray irradiation is key for the elevated expression of p‐eIF2α and ATF4, and therefore radio‐resistance. This finding guided to discover that metformin and 2‐DG are synergistic in reversing radio resistance by inhibiting p‐eIF2α and ATF4. Liposomes loaded with metformin and 2‐DG (M/D‐Lipo) are thus prepared for enhancing fractionated radiotherapy of CRC, which achieved satisfactory therapeutic efficacy in both local and metastatic CRC tumors by reversing radio‐resistance and preventing T lymphocyte exhaustion.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cancer Research and Treatments · Cancer, Hypoxia, and Metabolism · Cancer-related Molecular Pathways

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pathology the First Affiliated Hospital of Soochow University Soochow University Suzhou Jiangsu 215123 China

Department of Oncology Taizhou People's Hospital Affiliated to Nanjing Medical University Taizhou 225300 China

State Key Laboratory of Radiation Medicine and Protection School of Radiation Medicine and Protection & School for Radiological and Interdisciplinary Sciences (RAD‐X) Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions Suzhou Medical College Soochow University Suzhou Jiangsu 215123 China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Jiangsu Province · Beijing Xisike Clinical Oncology Research Foundation

References (35)

Show source-provided references
1. 10.1186/s13014-020-01695-010.1186/s13014-020-01695-0 ↗
2. 10.3322/caac.2003810.3322/caac.20038 ↗
3. 10.1053/j.gastro.2020.08.05010.1053/j.gastro.2020.08.050 ↗
4. 10.1001/jama.2019.484210.1001/jama.2019.4842 ↗
5. 10.4174/astr.2014.86.3.14310.4174/astr.2014.86.3.143 ↗
6. 10.1002/bjs.180081010610.1002/bjs.1800810106 ↗
7. 10.1016/j.radonc.2021.12.01810.1016/j.radonc.2021.12.018 ↗
8. 10.3748/wjg.v25.i33.485010.3748/wjg.v25.i33.4850 ↗
9. 10.1016/j.jncc.2022.02.00210.1016/j.jncc.2022.02.002 ↗
10. 10.1038/s41571-023-00815-510.1038/s41571-023-00815-5 ↗
11. 10.4161/cc.2452810.4161/cc.24528 ↗
12. 10.1080/0284186X.2019.163147310.1080/0284186X.2019.1631473 ↗
13. 10.1056/NEJMoa06082910.1056/NEJMoa060829 ↗
14. 10.1245/s10434-013-3198-910.1245/s10434-013-3198-9 ↗
15. 10.1097/00000658-197505000-0001710.1097/00000658-197505000-00017 ↗
16. 10.1038/s41586-023-05793-310.1038/s41586-023-05793-3 ↗
17. 10.1038/s42255-023-00783-110.1038/s42255-023-00783-1 ↗
18. 10.1016/j.cell.2012.01.03810.1016/j.cell.2012.01.038 ↗
19. 10.1016/j.cell.2018.04.01710.1016/j.cell.2018.04.017 ↗
20. 10.1002/adma.20200742610.1002/adma.202007426 ↗
21. 10.1016/j.ajps.2021.10.00410.1016/j.ajps.2021.10.004 ↗
22. 10.1021/acs.nanolett.0c0477810.1021/acs.nanolett.0c04778 ↗
23. 10.1016/j.cell.2022.07.02510.1016/j.cell.2022.07.025 ↗
24. 10.1038/s41568-023-00632-z10.1038/s41568-023-00632-z ↗
25. 10.1002/adma.20220734310.1002/adma.202207343 ↗
26. 10.1186/s13046-015-0221-y10.1186/s13046-015-0221-y ↗
27. 10.1016/j.molcel.2022.07.01210.1016/j.molcel.2022.07.012 ↗
28. 10.1016/j.canlet.2010.07.01610.1016/j.canlet.2010.07.016 ↗
29. 10.1016/j.cmet.2018.09.01910.1016/j.cmet.2018.09.019 ↗
30. 10.3390/ijms2101023410.3390/ijms21010234 ↗
31. 10.1158/0008-5472.CAN-22-304210.1158/0008-5472.CAN-22-3042 ↗
32. 10.1016/j.ccr.2006.10.02010.1016/j.ccr.2006.10.020 ↗
33. 10.1016/j.immuni.2021.05.00410.1016/j.immuni.2021.05.004 ↗
34. 10.1021/acs.jmedchem.1c0173710.1021/acs.jmedchem.1c01737 ↗
35. 10.1136/jitc-2022-00571910.1136/jitc-2022-005719 ↗